LENZ Therapeutics, Inc. insider trading

By person

16 insiders · 77 transactions

0.3×

Evert Schimmelpennink holds only 0.3 times base salary in stock. $259.69K of shares against $690.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Evert Schimmelpennink last reported holding, valued at $3.36, the price Common Stock was last bought or sold at on the open market here, on 29 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Versant Venture Capital VI, L.P. entity

10% owner

$3.06M (1)

$66.60M (34)

−$63.54M

3,522,445

$11.84M

—

Samsara BioCapital, L.P.

10% owner

$17.13M (16)

—

+$17.13M

8,497,067

$28.55M

—

Ra Capital Management, L.p. entity

10% owner

— (2)

$9.13M (3)

−$9.13M

4,071,653

$13.68M

+59.9%

Davis Jerel

Director

$3.06M (1)

—

+$3.06M

1,707,719

$5.74M

—

James W McCollum

Director

$740.37K (2)

—

+$740.37K

536,065

$1.80M

—

Shawn Olsson

Chief Commercial Officer

—

$261.02K (2) scheduled

−$261.02K

4,733

$15.90K

—

Evert B. Schimmelpennink

President, CEO and Secretary

$251.41K (1)

—

+$251.41K

77,289

$259.69K

—

Daniel R. Chevallard

Chief Financial Officer

$164.28K (4)

—

+$164.28K

12,886

$43.30K

—

Smital Shah

Director

$99.99K (1)

—

+$99.99K

5,882

$19.76K

—

Jeffrey P. George

Director

$49.89K (1)

—

+$49.89K

5,592

$18.79K

—

Phil Gutry

Chief Business Officer

$20.05K (1)

—

+$20.05K

299,941

$1.01M

+56.2%

Joshua Lehrer-Graiwer

President and CEO

—

1,161,670

$3.90M

+49.0%

Katherine Stultz V

Chief Operating Officer

—

216,020

$725.83K

+3.9%

Perry A Karsen

Director

—

164,034

$551.15K

+5.2%

Joseph Jimenez

Director

—

161,941

$544.12K

+55.8%

Marc Odrich

Chief Medical Officer

—

99,599

$334.65K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

LENZ Therapeutics, Inc.

What the insiders did Net selling

By person